Cornell RC, Stoughton RB. Topical Corticosteroids. Guidelines for therapy. Hoechst Aktiengesellschaft eds West Germany 1985, 66pp.

Schmidt JE. Medical Discoveries Who and When. Charles C Thomas Publisher, Springield, 1959 pp. 555.

Djerassi C. Desarrollo histórico de la investigación química de los corticoides. En: Treinta años de la Corticoterapia. Simposio Syntex. Eds Instituto Syntex, Nov 1978 pp. 8-19.

Goa KL Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs 1988;36(Suppl.5):51-61.

https://doi.org/10.2165/00003495-198800365-00011

Trópert M. Perspectives in corticosteroid research. Drugs 1988;36(Suppl.5)l-8.

https://doi.org/10.2165/00003495-198800365-00003

WendtH, Frosch Pj. Clínico-Pharmacological models for the assay of topical corticoids. S. Karger AG (Basilea) 1982 pp. 61.

Norris DA, Capin L Weston WL. The effect of epicutaneous flucocorticosteroids on human monocyte and neutrophil migration in vivo. J Invest Dermatol 1982;78:386-390.

https://doi.org/10.1111/1523-1747.ep12507510

Di Rosa M, Calignano AC Amuccio R, et al. Multiple control of inflamamtion by glucocorticoids. Agents and Actions 1985;17:284-289.

https://doi.org/10.1007/BF01982621

Flower RJ. Background and discovery of lipocortins. Agents and Actions 1985;17:255-261.

https://doi.org/10.1007/BF01982616

Maibach HI. In vivo percutaneous penetration of corticosteroids in man and unresolved problems in their efficacy. Dermatológica 1976;152(Suppl.l):ll-25.

https://doi.org/10.1159/000257863

Wester RC, Maibach HI. Cutaneous pharmacokinetics: 10 steps to percutaneous absortion. Drug Metabolism Reviews 1983;14:169-205.

https://doi.org/10.3109/03602538308991388

Vickers CFH. Existence of reservoir in the stratum comeum. Arch Dermatol 1963;88:72-75.

https://doi.org/10.1001/archderm.1963.01590190026002

du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol 1976;112:1245-1248.

https://doi.org/10.1001/archderm.1976.01630330015002

Clement M, Philips H, du Vivier A. Is steroid tachyphylaxis preventable? Clin Exp Dermatol 1985;10:22-29.

https://doi.org/10.1111/j.1365-2230.1985.tb02547.x

Maibach HI, Stoughton RB. Topical Corticosteroids. In: Azamoff E (Ed) Steroid therapy, pp 174-190 Saunders, Philadelphia, 1975.

Busse MJ. Dangers of dilutions of topical steroids. Pharm J, 1978;220:25-26.

Feldman R, Maibach HI. Penetration of 14C-hidrocortisone through normal skin: the effect of stripping and occlusion. Arch Dermatol 1965;91:661-664.

https://doi.org/10.1001/archderm.1965.01600120093023

Turpeinen M. Influencia of age and severity of dermatitis on the percutaneous absortion of hidrocortisone in children. Br J Dermatol 1988;118:517-522.

https://doi.org/10.1111/j.1365-2133.1988.tb02461.x

Stoughton RB, Weillich K. J Am Acad Dermatol 1990;22:1038-1041.

https://doi.org/10.1016/0190-9622(90)70148-B

Giannotti B. Current treatment guidelines for topical corticosteroids. Drugs 1988; 36(Supp.5):9-14.

https://doi.org/10.2165/00003495-198800365-00004

Takcda K, Arase S, Takahashi S. Side effects of topical corticosteroids and their prevention. Drugs 1988;36(Supp.5):15-

https://doi.org/10.2165/00003495-198800365-00005

Ortonne JP. Clinical Potential of Topical Corticosteroids Drugs 1988;36(Supp.5):3.8-42.

https://doi.org/10.2165/00003495-198800365-00008

Halobetasol propionate: atrihalogenated ultrapotent topical corticosteroid. J Am Acad Dermatol 1991;25(6 Part 3 Suppl.):1137-1186.